NEWS

• Suvoda Expands EU Patient Travel with Bolt Partnership

  New partnership offers EU clinical trial patients reliable, no-cost transportation, reducing travel burdens, improving retention, and supporting access across diverse populations.

• Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
• Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI

  AI-powered platform built on Google Cloud automates clinical trial tasks, reducing time, cost, and errors while generating regulatory-grade real-world evidence through human-supervised automation.

• Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies

  Almac Group has today announced a $48 million investment in eClinical technologies that includes the launch of Almac Trial Coordinator™ – a first-in-class interoperable clinical trial technology platform, enhancements to its eClinical ecosystem capabilities, and creation of over 100 advanced technology roles globally.

• Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions

  Biorasi has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.

• Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence

  Suvoda LLC, a global clinical trial technology company, announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name and brand.

• Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs

  Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical clinical trial inflection points.

• Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.

  Avance Clinical was honored to attend a special reception at the Executive Mansion in Raleigh, North Carolina, hosted by Governor Josh Stein to welcome His Excellency, The Honorable Kevin Rudd AC, Australia’s Ambassador to the United States.

• Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration

  Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.

• "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

  Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe. The report, “Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe” was published in the September 2025 issue of Value in Health.

• ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan

  ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific.

• Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity

  Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome Development (DECODE) in Obesity.

• Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture

  Quotient Sciences announced a new partnership with the UK CPI (Centre for Process Innovation) to help accelerate mRNA therapeutics — combining CPI capabilities in LNP manufacturing and technology with Quotient Sciences' clinical and drug product development platform, Translational Pharmaceutics®.

• Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights

  In a move set to redefine how biotech and biopharma sponsors plan and launch clinical trials, Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies, has partnered with Ryght AI & to bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.